Inozyme Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!About INZY
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.
CEODoug Treco Treco, PhD
CEODoug Treco Treco, PhD
Employees67
Employees67
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees67
Employees67
INZY Key Statistics
Market cap258.25M
Market cap258.25M
Price-Earnings ratio-2.38
Price-Earnings ratio-2.38
Dividend yield—
Dividend yield—
Average volume712.81K
Average volume712.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.10
52 Week high$6.10
52 Week low$0.722
52 Week low$0.722
People also own
Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.